Siragusa will lead One Drop’s efforts to introduce and expand access to affordable continuous glucose monitoring options for people with type 2 diabetes, prediabetes, and other chronic conditions
Bigfoot Biomedical announced today that it has acquired the intellectual property assets of Common Sensing, a Cambridge, MA-based company that develops and manufactures data-driven hardware and software solutions for people using injectable medicine, including Gocap. Last month, Bigfoot received FDA clearance for its Bigfoot Unity™ Diabetes Management System featuring first-of-its-kind smart pen caps for insulin pens used to treat Type 1 and Type 2 diabetes. Integrated with Abbott’s FreeStyle® Libre 2 system, the Bigfoot Unity System is the first and only solution to translate continuously monitored glucose data into on-demand insulin dose recommendations, based on HCP instructions, displayed right on the pen-cap screen for ease of use.
#product & service
#insulin pen
Brighter AB (Publ) announced today that Chief Financial Officer Ann Zetterberg has chosen to leave Brighter to pursue new opportunities. While she is stepping down from her active role as CFO, Ann will continue with the Company in an advisory capacity until August 16, 2021 to ensure a smooth transition. The Company has commenced a search for the next CFO.
In a recent conversation with YourStory’s Daily Dispatch, Arbinder Singal, Co-Founder and CEO, FitterFly, shares valuable insights on the journey of the health-tech company through the pandemic and plans for the future.
#dtx
The awards recognise organisations that have made outstanding contributions to their industry and are positioned to make a significant impact in the future.
Smart Meter, the leader in cellular-enabled remote patient monitoring (RPM) data and devices in many areas including diabetes, announced the launch of iScale, a cellular-connected body weight scale. This addition further expands its suite of healthcare products, which include iGlucose for diabetes monitoring and iBloodPressure for hypertension management, to enhance traditional chronic condition management.
Data Showcases the Company's Most Advanced Product Portfolio Designed to Meet Patients Where They Are In Their Diabetes Journey
#insulin pen
Following the release of its initial pivotal trial results in March, Insulet will present new clinical outcomes data for preschool children with type 1 diabetes using the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the first tubeless automated insulin delivery system with the option for full control by a user’s compatible smartphone to simplify life for people living with diabetes.
#insulin pump
The program features first-of-its-kind technologies and a cloud-based platform that seamlessly connects clinics and health care providers to their Bigfoot Unity patients to enable continuous, proactive care — with or without an office visit.
A leading provider of scalable digital health coaching in Europe, Liva Healthcare (“Liva”), today announced its expansion to the German market to help combat the country’s rise in type 2 diabetes and obesity.